Reply to letter to the editor: Subfoveal Choroidal Thickness as a Predictor of Treatment Response to Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy

Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1653. doi: 10.1007/s00417-016-3369-z. Epub 2016 Apr 26.

Authors

Hyesun Kim^{1

2}, Sung Chul Lee¹, Kye Yoon Kwon¹, Christopher Seungkyu Lee³

Affiliations

¹ The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul, 120-752, Korea.
² Siloam Eye Hospital, Seoul, Korea.
³ The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul, 120-752, Korea. [email protected].

PMID: 27116214
DOI: 10.1007/s00417-016-3369-z

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors
Choroid / blood supply*
Fluorescein Angiography
Humans
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A*
Visual Acuity
Wet Macular Degeneration

Substances

Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A